Searchable abstracts of presentations at key conferences in endocrinology

ea0094p85 | Neuroendocrinology and Pituitary | SFEBES2023

Development of an optimal imaging pathway for management of somatotroph tumors in acromegaly

Haberbosch Linus , Macfarlane James , Koulouri Olympia , Gillett Dan , Spranger Joachim , Mai Knut , Cheow Heok , Jones Jonathan , Strasburger Christian , Gurnell Mark

Background: Acromegaly is associated with significant excess morbidity and mortality. Surgery and radiotherapy (including radiosurgery) aim to reduce the burden of growth hormone excess while preserving normal pituitary function, but their effective deployment is dependent on high quality imaging that allows accurate localization of site(s) of active de novo or residual/recurrent disease. Despite the existence of several comprehensive guidelines on the managem...

ea0094op8.1 | Late Breaking Abstracts Respectively | SFEBES2023

Real-world experience with 11C-methionine PET co-registered with MRI in the management of acromegaly – Insights from a single reference centre 12 year observation

Haberbosch Linus , MacFarlane James , Koulouri Olympia , Gillett Daniel , Huynh Kevin A. , Jones Jonathan , Cheow Heok K. , Spranger Joachim , Mai Knut , Strasburger Christian J. , Mannion Richard , Gurnell Mark

Background: 11C-methionine positron emission tomography (Met-PET) is a potentially important imaging adjunct in the diagnostic workup of pituitary adenomas, including somatotroph tumours. Met-PET can identify residual or occult disease and make definitive therapies accessible for a subgroup of patients who would otherwise require lifelong medical therapy. However, data on its use is still limited to small case series. Here, we report the currently largest sing...